According to new epidemiological data from the Nigeria Center for Disease Control NCDC, the number of COVID19 cases in the country has increased by 77% in a week.
COVID19 instances increased from 392 two weeks ago to 693 last week, according to the statistics (July 5 to July 11). According to the study, the number of discharges (recoveries) has decreased by 87 percent from 433 discharged two weeks ago to 57 discharged last week.
According to the study, testing improved by 29% in the last week, from 28,656 tests in 32 states to 36,965 tests in 34 states. Seven states did poorly, with fewer than ten persons tested in a week.
Bauchi (1), Sokoto (1), Zamfara (1), Kogi (3), Yobe (3), Nasarawa (5), Niger (5), Lagos (15,673), Federal Capital Territory (5,405), and Rivers (3,991) tested the most COVID-19 samples.
READ ALSO: “Shame On Anyone Who Backs What Transpired In Anambra And Still Laments About The Country” – Governor Yahaya Bello’s Media Aide Says
Dr. Chikwe Ihekweazu, Director-General of the National Center for Disease Control and Prevention, reacted to the latest developments by urging Nigerians to take the COVID19 guidelines seriously, especially now that the hazardous Delta variant has been discovered in the country.
“Given the high transmissibility of the Delta variant and following its detection in Nigeria, NCDC urges all Nigerians to ensure strict adherence to public health and social measures in place.
Proven public health and social measures such as physical distancing, frequent handwashing, and proper use of face masks, prevent infections and save lives. The COVID-19 vaccine is safe and effective and offers protection against the disease.
Additionally, states are urged to ensure sample collection and testing for COVID-19 is accessible to the public. Public settings such as schools with accommodation facilities, workplaces and camps should utilise the approved Antigen based Rapid Diagnostic Test (RDT) for rapid testing of their population.” he said
According to researchers, the Delta form is 50% more contagious than the Alpha type, which was first discovered in the United Kingdom. Vaccines and certain COVID-19 treatments may not be effective against the Delta version, while research is currently underway.